Tandem Diabetes Care, Inc.TNDMNASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 60.26% |
| Q2 2025 | 60.41% |
| Q1 2025 | -17380.70% |
| Q4 2024 | 103.26% |
| Q3 2024 | 25.53% |
| Q2 2024 | 27.69% |
| Q1 2024 | -41.30% |
| Q4 2023 | 9.80% |
| Q3 2023 | 7.27% |
| Q2 2023 | 71.35% |
| Q1 2023 | -668.00% |
| Q4 2022 | 67.11% |
| Q3 2022 | -230.43% |
| Q2 2022 | 0.00% |
| Q1 2022 | -235.29% |
| Q4 2021 | 88.89% |
| Q3 2021 | 50.00% |
| Q2 2021 | 174.26% |
| Q1 2021 | -129.93% |
| Q4 2020 | 280.00% |
| Q3 2020 | 66.67% |
| Q2 2020 | -80.00% |
| Q1 2020 | -725.00% |
| Q4 2019 | 181.14% |
| Q3 2019 | -89.62% |
| Q2 2019 | 93.50% |
| Q1 2019 | -766.67% |
| Q4 2018 | 109.68% |
| Q3 2018 | 47.01% |
| Q2 2018 | 35.71% |
| Q1 2018 | -47.97% |
| Q4 2017 | 60.19% |
| Q3 2017 | 29.13% |
| Q2 2017 | 41.55% |
| Q1 2017 | -55.42% |
| Q4 2016 | 50.67% |
| Q3 2016 | -61.90% |
| Q2 2016 | 11.09% |
| Q1 2016 | -68.58% |
| Q4 2015 | 38.50% |